Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Selectins01:25

Selectins

Cell adhesion is  an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain, which...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Breaking the operator variability in Kibler's scapular dyskinesis assessment.

Musculoskeletal surgery·2024
Same author

Conduction-Radiation Coupling between Two Closely Separated Solids.

Physical review letters·2020
Same author

A new MEFV gene mutation in an Iranian patient with familial Mediterranean fever.

Reumatismo·2019
Same author

Trends in immune cell function assay and donor-specific HLA antibodies in kidney transplantation: A 3-year prospective study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013
Same author

Antifeedant and toxic effects of sesquiterpenes fromSenecio palmensis to colorado potato beetle.

Journal of chemical ecology·2013
Same author

Indole alkaloids from Geissospermum reticulatum.

Journal of natural products·2012

Related Experiment Video

Updated: Jun 21, 2026

Induction of Adhesion-dependent Signals Using Low-intensity Ultrasound
08:51

Induction of Adhesion-dependent Signals Using Low-intensity Ultrasound

Published on: May 8, 2012

Is syndecan-2 a key angiogenic element?

O Noguer1, M Reina

  • 1Department of Cellular Biology, Faculty of Biology, University of Barcelona, Av. Diagonal 645, 08028, Barcelona, Catalonia, Spain. onoguer@ub.edu

Thescientificworldjournal
|August 4, 2009
PubMed
Summary

Syndecan-2, a key proteoglycan in human microvascular endothelial cells, is vital for new blood vessel formation. It cooperates with integrins, aiding cellular events in neovascularization and disease progression.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biomedical Research

Background:

  • Angiogenesis is implicated in various diseases, including cancer and cardiovascular disorders.
  • Syndecan-2 is a major heparan sulfate proteoglycan in human microvascular endothelial cells.
  • Previous work indicated syndecan-2 is regulated by proangiogenic factors.

Purpose of the Study:

  • To elucidate the role of syndecan-2 in neovascularization processes.
  • To investigate syndecan-2's function in cellular events during new blood vessel formation.
  • To explore syndecan-2's interaction with the cytoskeleton and integrins.

Main Methods:

  • Analysis of syndecan-2 regulation by proangiogenic factors.
  • Investigation of syndecan-2's role in cellular events of neovascularization.

More Related Videos

Strategic Endothelial Cell Tube Formation Assay: Comparing Extracellular Matrix and Growth Factor Reduced Extracellular Matrix
08:46

Strategic Endothelial Cell Tube Formation Assay: Comparing Extracellular Matrix and Growth Factor Reduced Extracellular Matrix

Published on: August 14, 2016

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits
07:34

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits

Published on: June 2, 2019

Related Experiment Videos

Last Updated: Jun 21, 2026

Induction of Adhesion-dependent Signals Using Low-intensity Ultrasound
08:51

Induction of Adhesion-dependent Signals Using Low-intensity Ultrasound

Published on: May 8, 2012

Strategic Endothelial Cell Tube Formation Assay: Comparing Extracellular Matrix and Growth Factor Reduced Extracellular Matrix
08:46

Strategic Endothelial Cell Tube Formation Assay: Comparing Extracellular Matrix and Growth Factor Reduced Extracellular Matrix

Published on: August 14, 2016

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits
07:34

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits

Published on: June 2, 2019

  • Assessment of syndecan-2's involvement in cytoskeletal reorganization.
  • Main Results:

    • Syndecan-2 is regulated by proangiogenic factors.
    • Syndecan-2 plays a significant role in cellular events during neovascularization.
    • Syndecan-2 is involved in cytoskeletal reorganization.
    • Syndecan-2 acts as an adaptor protein cooperating with integrins.

    Conclusions:

    • Syndecan-2 is a crucial proteoglycan in angiogenesis.
    • Syndecan-2's interaction with integrins is essential for new blood vessel formation.
    • Syndecan-2 is a potential therapeutic target for angiogenesis-related diseases.